Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model
AIM: To clarify the mechanism of infliximab treatment in diabetic macular edema (DME) and to provide a new alternative therapy for DME. METHODS: Rats were randomly divided into the control group, the model group and the infliximab treatment group. A diabetic rat model was created. The concentration...
Main Authors: | Mao-Song Xie, Yong-Zheng Zheng, Li-Bin Huang, Guo-Xing Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-12-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.cn/en_publish/2017/12/20171206.pdf |
Similar Items
-
The role of plasmalemma vesicle-associated protein in pathological breakdown of blood–brain and blood–retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema
by: Esmeralda K. Bosma, et al.
Published: (2018-09-01) -
Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet’s Disease
by: Junko Ikewaki, et al.
Published: (2010-06-01) -
Intravitreal injection of Ranibizumab combined with retinal photocoagulation for CRVO with retinal neovascularization and macular edema
by: Yong Wang
Published: (2018-06-01) -
Efficacy of retinal photocoagulation combined with Ranibizumab or Conbercept in patients with macular edema secondary to retinal vein occlusion
by: Ting Chen, et al.
Published: (2018-09-01) -
Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)